Emotional Prosody Recognition and Decision Making Inf fMRI and Vulnerability to Suicide

NCT ID: NCT02901769

Last Updated: 2016-09-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-02-28

Study Completion Date

2020-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Suicide is known to be frequent in depression, and in most of the psychiatric diseases. But as it can occur in patients with no psychiatric illness and doesn't occur in every patients with psychiatric illness, it has to be considered henceforth as a specific vulnerability.

This trial will study two fMRI paradigms, emotional prosody recognition and decision making, in order to characterize emotional and cognitive trait factors in a population of patients vulnerable to suicide. Four different groups will be constituted : depressed suicide attempters, depressed patients with past history of suicidal acts, depressed patients with no history of suicidal acts and healthy controls.

The main goal will be to correlate fMRI activation during the two paradigms in subjects vulnerable to suicide. The secondary goals will be to characterize emotional and cognitive trait factors in these subjects, to demonstrate that those characteristics are independent from depression and to correlate these trait factors with socio-demographic and clinical features with fMRI activations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suicide

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Depressed suicide attempters

20 subjects

Group Type EXPERIMENTAL

fMRI

Intervention Type OTHER

two fMRI paradigms, emotional prosody recognition and decision making

Depressed patients with past history of

20 subjects

Group Type EXPERIMENTAL

fMRI

Intervention Type OTHER

two fMRI paradigms, emotional prosody recognition and decision making

Depressed patients with no history of

20 subjects

Group Type EXPERIMENTAL

fMRI

Intervention Type OTHER

two fMRI paradigms, emotional prosody recognition and decision making

Healthy controls

20 subjects

Group Type PLACEBO_COMPARATOR

fMRI

Intervention Type OTHER

two fMRI paradigms, emotional prosody recognition and decision making

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fMRI

two fMRI paradigms, emotional prosody recognition and decision making

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Right-handed,
* Depressed suicide attempters for the first group,
* Depressed patients with past history of suicidal acts for the second group,
* Depressed patients with no history of suicidal acts for the third group,
* Healthy controls for the fourth group.

Exclusion Criteria

* Another psychiatric trouble than depression,
* Another psychotrope treatment than SSRI/SNRI and/or benzodiazepine at inclusion and/or one month before,
* For the first and secand groups : more than fous suicidals acts within the past 3 years,
* Deficits that do not allow test realisation (visual audition troubles, cognitif deficits,
* Prosopagnosia,
* Pregnancy,
* Severe central nervous system disease or somatic disease,
* MRI contra-indication,
* Major benefiting from a legal protective measure,
* No coverage care.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rennes university hospital

Rennes, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David Travers, MD

Role: CONTACT

02 99 28 67 67

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-A00944-37

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brain, Emotions, and Mind-Wandering
NCT05345392 RECRUITING NA